ExLibris header image
SFX Logo
Title: Affinity labeling of muscarinic receptors in rat cerebral cortex with a photolabile antagonist.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Amitai, G yr:1982


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Fisher, A. "M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy." Journal of molecular neuroscience 20.3 (2003): 349-356. Link to SFX for this item
2. Wessler, I. "Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans." British journal of pharmacology 154.8 (2008): 1558-1571. Link to Full Text for this item Link to SFX for this item
3. KOLLER, J T J. "N-ACETYL-ASPARTYL-GLUTAMATE - REGIONAL LEVELS IN RAT-BRAIN AND THE EFFECTS OF BRAIN-LESIONS AS DETERMINED BY A NEW HPLC METHOD." Journal of neurochemistry 43.4 (1984): 1136-1142. Link to Full Text for this item Link to SFX for this item
4. Shen, Z X X. "Brain cholinesterases: II. The molecular and cellular basis of Alzheimer's disease." Medical Hypotheses 63.2 (2004): 308-21. Link to SFX for this item
5. Dong, A. "Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease." Psychopharmacology 181.1 (2005): 145-52. Link to SFX for this item
6. Tsunekawa, H. "Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35)." Behavioural Brain Research 190.2 (2008): 224-232. Link to SFX for this item
7. Mudher, A. "Alzheimer's disease-do tauists and baptists finally shake hands?" Trends in Neurosciences 25.1 (2001): 22-6. Link to Full Text for this item Link to SFX for this item
8. Lovestone, S. "Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct." Alzheimer disease and associated disorders 9.4 (1995): 218-222. Link to SFX for this item
9. D'Adamo, A F. "N-acetyl-aspartate amidohydrolase: purification and properties." Journal of neurochemistry (1977): 739-744. Link to Full Text for this item Link to SFX for this item
10. GILVARG, C. "Creatine and creatine kinase measurement." The Journal of biological chemistry 234.12 (1959): 3201-3204. Link to SFX for this item
11. Michaelis, T. "Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra." Radiology 187.1 (1993): 219-27. Link to SFX for this item
12. Centenaro, L. "Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex." Psychopharmacology 201.2 (2008): 237-248. Link to SFX for this item
13. Eckelman, W. "Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine." Drug discovery today 13.17-18 (2008): 748-759. Link to SFX for this item
14. ten Bruggencate, G. "Iontophoretic studies in Deiters' nucleus of the inhibitory actions of GABA and related amino acids and the interactions of strychnine and picrotoxin." Brain Research 25.3 (1971): 431-48. Link to Full Text for this item Link to SFX for this item
15. Loizzo, M. "Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: An update." Current medicinal chemistry 15.12 (2008): 1209-1228. Link to SFX for this item
16. Eglen, M. "Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function." Autonomic & autacoid pharmacology 26.3 (2006): 219-233. Link to SFX for this item
17. Turner, S. "Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease." Learning & memory 9.5 (2002): 243-52. Link to Full Text for this item Link to SFX for this item
18. Jacobs, J. "Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group." Neurology 53.8 (1999): 1698-704. Link to SFX for this item
19. Hardy, J. "Amyloid deposition as the central event in the aetiology of Alzheimer's disease." Trends in pharmacological sciences 12.10: 383-388. Link to SFX for this item
20. Wang, J. "Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease." The FASEB journal 20.13 (2006): 2313-20. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.